Genmab
GMAB
GMAB
216 hedge funds and large institutions have $1.62B invested in Genmab in 2023 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 75 increasing their positions, 94 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
16% less capital invested
Capital invested by funds: $1.94B → $1.62B (-$318M)
20% less repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 94
40% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 42
Holders
216
Holding in Top 10
2
Calls
$6.37M
Puts
$4.18M
Top Buyers
| 1 | +$16.3M | |
| 2 | +$13.1M | |
| 3 | +$9.85M | |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
+$8.94M |
| 5 |
Jane Street
New York
|
+$7.2M |
Top Sellers
| 1 | -$28M | |
| 2 | -$27.4M | |
| 3 | -$24.4M | |
| 4 |
Millennium Management
New York
|
-$23.1M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$20.4M |